Acquired and genetic risk factors for deep vein thrombosis of lower extremities among Lebanese patients.

Authors: Kreidy R,Waked M,Stephan E,Irani J,Chemali R,Jureidini I,Irani-Hakime N,
Address: Division of Vascular Surgery, Saint George Hospital and University of Balamand, Beirut, Lebanon. docrkdy@inco.com.lb
Journal: J Med Liban.

Publication: 2012 Jan-Mar;60(1):24-9.

abstract

AIM:

Venous thrombosis results from the interaction of environmental and genetic risk factors. These factors vary according to the ethnic and geographic distribution of the populations. The aim of this study is to define the role of Acquired and genetic risk factors for venous thrombosis of lower extremities among Lebanese patients assessed in a university hospital and to discuss them according to the international literature.

MATERIAL AND METHODS:

From January 2005 to January 2010, 166 patients (72 males and 94 females) were diagnosed with lower extremity deep vein thrombosis. Mean age was 67 years (range: 25 to 96 years).

RESULTS:

The most frequently reported acquired risk factors for venous thrombosis in this study were advanced age, obesity, history of venous thromboembolism, immobilization, surgery, varicose veins and malignancy. Screening for prothrombotic genetic abnormalities was requested in patients with conditions highly suggestive of hypercoagulation state such as young patients, patients with spontaneous, recurrent or extensive venous thrombosis, patients with family history, oral contraceptives, air travel and pregnancy. All the 45 patients (27.1%) tested for thrombophilia were positive and were carriers for factors V-Leiden (17.4%), MTHFR C 677 T (16.8%), MTHFR A 1298 C (4.8%), II G 20210 A (1.8%) and V H 1299 R (1.2%) mutation. Twelve patients (7.2%) had increased homocysteine level.

CONCLUSION:

Advanced age is the most common risk factor for venous thrombosis in these series. Thrombophilia is the second most frequently observed risk factor and is related to the high prevalence of factor V-Leiden and MTHFR C 677 T mutation among the Lebanese population.

Related Articles
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
Vasc Health Risk Manag. 2009
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
Kreidy R, Irani-Hakime N. Vasc Health Risk Manag. 2009; 5:627-33. Epub 2009 Aug 6.
Lower extremity venous thrombosis in patients younger than 50 years of age.
Vasc Health Risk Manag. 2012
Lower extremity venous thrombosis in patients younger than 50 years of age.
Kreidy R, Salameh P, Waked M. Vasc Health Risk Manag. 2012; 8:161-7. Epub 2012 Mar 13.
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Haematologica. 2000
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F. Haematologica. 2000 Dec; 85(12):1271-6.
Review Factor V Leiden: should we screen oral contraceptive users and pregnant women?
BMJ. 1996
Review Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. BMJ. 1996 Nov 2; 313(7065):1127-30.
Review Genetic risk factors of venous thrombosis.
Hum Genet. 2001
Review Genetic risk factors of venous thrombosis.
Franco RF, Reitsma PH. Hum Genet. 2001 Oct; 109(4):369-84.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.